Navigation Links
USPTO Allows NivaSonix Core Patent - 'External Ultrasound Lipoplasty'
Date:2/8/2011

CARPINTERIA, Calif., Feb. 8, 2011 /PRNewswire/ -- NivaSonix, LLC announced today the allowance by the U. S. Patent and Trademark Office (USPTO) of its core patent "External Ultrasound Lipoplasty".  Nine additional U.S. and international patents are pending with additional patent filings in progress.  The patent describes a technology that allows a new generation of non-invasive ultrasound therapy for both fat and wrinkle reduction targeted for patients worldwide.

NivaSonix has successfully developed a unique and differentiating way to selectively deliver ultrasound energy based on its proprietary "Sweeping Multizone Focus™" ("SMF™") technology.  Fully functional prototypes have been built and tested to prove the concept, which has been confirmed via live animal and human tissue testing.  Additional testing to support applications for domestic and international regulatory approvals is underway.

The NivaSonix ULLISYS™ system is based on a flexible and expandable product platform, designed for both skin tightening (wrinkle reduction) and lipoplasty (fat emulsification) – multi-billion dollar market opportunities.

"We are pleased to receive the notice of allowance of our patent – this innovative, broad technology and product should benefit both patients and surgeons," commented Bobby Purkait, President and CEO of NivaSonix.

About NivaSonix:

NivaSonix, LLC is a privately funded, California limited liability company headquartered in Carpinteria, CA. NivaSonix, LLC is a technology based company involved in the research and development, manufacture and commercialization of non-invasive ultrasound medical device systems for aesthetic, dermatology and other cosmetic and personal care markets.  The Company is led by a highly experienced, cross-functional management team with direct experience in global commercialization of ultrasound based body contouring products.


'/>"/>
SOURCE NivaSonix, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. KemPharm, Inc. Receives Notice of Issuance from USPTO on Second Patent Protecting Companys ADHD Prodrug Technology
2. KemPharm, Inc. Receives Notice of Issuance From USPTO on Patent Protecting Companys ADHD Prodrug Technology
3. New Online Pharmacy Rx-webmasters.com Allows Customers to Pay Less for High-Quality Drugs
4. Social Media Research Service Allows Pharmaceutical Marketers to Monitor Brand Health
5. Usability Sciences Corporation Launches WebIQ Pharma - An Intelligent Survey Tool That Allows Pharma Sites to Measure and Improve Website Effectiveness
6. Healthcare Scoring System Allows Hospitals To Increase Charity Care
7. New Florida Law Allows Use of Instant Drug Tests On the Job Site
8. United States Patent Office Allows Claims Covering the Approved Administration of Kuvan with Food
9. UCB and PDL BioPharma Resolve Patent Disputes
10. ISTO Technologies Awarded Key Patent for NuQu™ Injectable Therapy for Degenerative Disc Disease
11. Generex Oncology Receives New Patent for AE37 Immunotherapeutic Cancer Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... YORK , December 2, 2016 ... the trading session in red, while the Dow Jones Industrial ... at the close of US markets, which prompted Stock-callers this ... stocks: NuVasive Inc. (NASDAQ: NUVA ), Smith & ... (NASDAQ: NXTM ), and Cesca Therapeutics Inc. (NASDAQ: ...
(Date:12/2/2016)... -- Research and Markets has announced the addition ... Technologies, Markets and Companies" to their offering. ... , , ... The market value of drug delivery technologies and the anticancer ... given according to organs involved and the types of cancer as ...
(Date:12/2/2016)... , Dec. 1, 2016  Today, Simpson Healthcare Executives, ... honor of being selected as winners of multiple awards ... Executives Website at the PLATINUM level, Blue Zones Menu ... at the GOLD Level, and our proprietary 3ConneX Platform ... Simpson Healthcare Executives, we are excited to showcase our ...
Breaking Medicine Technology:
(Date:12/2/2016)... ... ... Rijuven Corp launches rejiva ( http://www.rejiva.com ), a unique wearable technology that measures ... on the market can deliver all that rejiva can. , “Rejiva promotes relaxation and ... than the usual heart rate and steps taken”, adds Evens Augustin, CEO of Rijuven. ...
(Date:12/2/2016)... ... December 02, 2016 , ... ... to needy individuals and families from eight different sites throughout Miami-Dade and Broward ... Over 1,000 volunteers worked very hard on Thanksgiving morning by putting together individual ...
(Date:11/30/2016)... Boston, Massachusetts (PRWEB) , ... November 30, 2016 ... ... is proud to announce that we have been designated as a Cigna Infertility ... meet or exceed rigorous performance standards. , “It’s an honor to be ...
(Date:11/30/2016)... ... November 30, 2016 , ... ... treatment has announced the opening of a new eating disorder treatment center location ... outpatient treatment for adults and adolescents, both males and females ages 10 and ...
(Date:11/30/2016)... ... 2016 , ... The Clinical Data Interchange Standards Consortium (CDISC) ... goes into effect next month. Sponsors whose studies start after December 17, 2016 ... The current FDA Data Standards Catalog specifies the use of CDISC standards: ...
Breaking Medicine News(10 mins):